← Open Payments lookup

LYUBOV LUPYAN-TEYTELMAN: Open Payments

NPI 1033230693 · FAIRFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,144 in 92 payments from 17 companies in 2025. Trend: 2023 $1,270 · 2024 $1,376 · 2025 $2,144

Food & beverage: $2,144
CompanyPaymentsAmount
ABBVIE INC.23$510
Janssen Biotech, Inc.12$399
Ardelyx, Inc.8$218
Aimmune Therapeutics, Inc.12$209
Madrigal Pharmaceuticals9$185
Takeda Pharmaceuticals U.S.A., Inc.8$184
Lilly USA, LLC3$86
Intercept Pharmaceuticals, Inc.4$80
QOL Medical, LLC3$66
Gilead Sciences, Inc.2$60

Products named: TREMFYA, IBSRELA, ZENPEP, RINVOQ, REZDIFFRA, ENTYVIO, LINZESS, SKYRIZI.

Industry payments across CA — which companies pay providers there.